naltrexone has been researched along with Corneal Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| McLaughlin, PJ; Purushothaman, I; Sassani, JW; Zagon, IS | 1 |
| Ljubimov, AV | 1 |
| Immonen, JA; McLaughlin, PJ; Sassani, JW; Zagon, IS | 1 |
| Klocek, MS; McLaughlin, PJ; Sassani, JW; Zagon, IS | 1 |
| Carroll, MA; McLaughlin, PJ; Sassani, JW; Zagon, IS | 1 |
| Abdelkader, H; Alany, RG; McGhee, CNj; Patel, DV | 1 |
| Abdelkader, H; Al-Kassas, R; Alany, RG; Wu, Z | 1 |
4 review(s) available for naltrexone and Corneal Diseases
| Article | Year |
|---|---|
Ocular surface complications in diabetes: The interrelationship between insulin and enkephalin.
Topics: Animals; Corneal Diseases; Diabetes Complications; Diabetes Mellitus; Dry Eye Syndromes; Enkephalins; Humans; Insulin; Naltrexone; Narcotic Antagonists; Receptors, Opioid | 2021 |
Diabetic complications in the cornea.
Topics: Aldehyde Reductase; Animals; Corneal Diseases; Diabetes Complications; Disease Models, Animal; Enzyme Inhibitors; Humans; Insulin; Naltrexone; Wound Healing | 2017 |
Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.
Topics: Analgesics, Opioid; Animals; Corneal Diseases; Diabetes Complications; Disease Models, Animal; Epithelium; Humans; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Wound Healing | 2010 |
New therapeutic approaches in the treatment of diabetic keratopathy: a review.
Topics: Animals; Cornea; Corneal Diseases; Diabetes Complications; Epithelium, Corneal; Humans; Insulin; Naltrexone; Nerve Growth Factors; Nicergoline; Trigeminal Ganglion; Wound Healing | 2011 |
3 other study(ies) available for naltrexone and Corneal Diseases
| Article | Year |
|---|---|
Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone.
Topics: Administration, Topical; Animals; Blood Glucose; Corneal Diseases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dry Eye Syndromes; Epithelium, Corneal; Fluorophotometry; Intraocular Pressure; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Ophthalmic Solutions; Re-Epithelialization; Tears; Wound Healing | 2014 |
Topical application of naltrexone facilitates reepithelialization of the cornea in diabetic rabbits.
Topics: Analysis of Variance; Animals; Blood Glucose; Body Weight; Corneal Diseases; Diabetes Complications; Disease Models, Animal; Enkephalin, Methionine; Epithelium, Corneal; Intraocular Pressure; Male; Naltrexone; Narcotic Antagonists; Rabbits; Regeneration; Time Factors | 2010 |
Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects.
Topics: Administration, Ophthalmic; Corneal Diseases; Diabetes Complications; Drug Stability; Light; Lipids; Liposomes; Naltrexone; Narcotic Antagonists; Oxidation-Reduction; Particle Size; Photolysis; Rheology; Viscosity | 2012 |